In a Q&A with ILCN, Dr. William K. Evans weighs in on vaping and flavored tobacco regulations as well as cessation and prevention efforts. Read more
IASLC selects multidisciplinary slate of physicians to chair WCLC 2024 and announces last call for abstracts for TTLC 2023. Read more
US Food and Drug Administration approves two combinations for non-small cell lung cancer. Read more
Prof. Denis Horgan, executive director for the European Alliance for Personalised Medicine, writes that while the intentions behind the EU’s new cancer screening recommendations are laudable, they lack a roadmap for turning ideas into reality. Read more
In Part 2 of our series on non-traditional methods to help patients quit smoking, Dr. Deepti Behl says it is important for healthcare providers to encourage their patients to quit smoking using current best practices as well as any other safe modality the patient perceives as helpful. Read more
While the harmful effects of smoking are well known, the negative impacts of continued smoking after a cancer diagnosis are underappreciated. With Lung Cancer Awareness Month under way, the association aims to change that with its new statement on tobacco cessation. Read more
Drs. Stephanie Saw and Daniel Tan stress the importance of understanding the intricacies of HER2 testing in non-small cell lung cancer to optimize patient selection. Read more
Go2 Foundation coordinates educational events across the United States to improve lung cancer awareness; abstract submissions open for 2023 European Lung Cancer Congress; and registration begins for inaugural Texas Lung Cancer Conference. Read more
During a lecture at NACLC 22, Dr. Christian Rolfo illustrated how ctDNA could be used to monitor progression and inform treatment decisions. Read more
During a networking panel at NACLC 22, CEO Karen Kelly and President Heather Wakelee joined program co-chairs Drs. Jessica Donington, Marina Chiara Garassino, and Jyoti Patel for a discussion with other women in the field. Read more